title: Path of least resistance. New drug development guidance needed from FDA.
authors.forename: Bob
authors.initials: B
authors.lastname: Huff
mesh_terms: D019380:Anti-HIV Agents; D017408:Guidelines as Topic; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D019380:Anti-HIV Agents